Inhibition of JAK-STAT and NF-κB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 239, 117045
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitusJournal of Cellular Biochemistry, 2013
- Inhibition of JAKs in Macrophages Increases Lipopolysaccharide-Induced Cytokine Production by Blocking IL-10–Mediated FeedbackThe Journal of Immunology, 2012
- Diabetes Mellitus and the β Cell: The Last Ten YearsCell, 2012
- Acute-phase proteins: As diagnostic toolJournal of Pharmacy and Bioallied Sciences, 2011
- SOCS proteins causing trouble in insulin actionActa Physiologica, 2007
- Aspirin and Salicylate Suppress Polymorphonuclear Apoptosis Delay Mediated by Proinflammatory StimuliThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Inflammation and the etiology of type 2 diabetesDiabetes/Metabolism Research and Reviews, 2005
- Inhibitors of Cytokine Signal TransductionJournal of Biological Chemistry, 2004
- SOCS Proteins: Negative Regulators of Cytokine SignalingStem Cells, 2001
- NF-κB: a key role in inflammatory diseasesJournal of Clinical Investigation, 2001